Whole-body MRI added to gadoxetic acid-enhanced liver MRI for detection of extrahepatic disease in patients considered eligible for hepatic resection and/or local ablation of colorectal cancer liver metastases.

Whole-body MRI added to gadoxetic acid-enhanced liver MRI for detection of extrahepatic disease in patients considered eligible for hepatic resection and/or local ablation of colorectal cancer liver metastases. Acta Radiol. 2019 Jun 12;:284185119855184 Authors: Sivesgaard K, Larsen LP, Sørensen M, Kramer S, Schlander S, Amanavicius N, Mortensen FV, Pedersen EM PMID: 31189329 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31189329?dopt=Abstract

Source: Acta Radiologica - June 11, 2019 Category: Radiology Authors: Sivesgaard K, Larsen LP, Sørensen M, Kramer S, Schlander S, Amanavicius N, Mortensen FV, Pedersen EM Tags: Acta Radiol Source Type: research